Lilly’s Weight Loss Sets High Bar for Obesity Drug Race

Sam Fazeli, Director of Research for Global Industries and Senior Pharmaceuticals Analyst for Bloomberg Intelligence, joined Bloomberg's Scarlett Fu and Paul Sweeney to discuss the gains and losses in the GLP1 market. (Source: Bloomberg) This story was reported by Bloomberg. For more Finance news in Kenya, stay tuned to Masaa.